Pyxis Oncology
PYXS
PYXS
88 hedge funds and large institutions have $29.6M invested in Pyxis Oncology in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
40% less capital invested
Capital invested by funds: $49.2M → $29.6M (-$19.6M)
45% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
88
Holding in Top 10
2
Calls
$41K
Puts
$36K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$286K | |
| 3 | +$283K | |
| 4 |
Morgan Stanley
New York
|
+$200K |
| 5 |
6CM
683 Capital Management
New York
|
+$132K |
Top Sellers
| 1 | -$939K | |
| 2 | -$597K | |
| 3 | -$486K | |
| 4 |
PA
Perceptive Advisors
New York
|
-$294K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$268K |
